Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
Abedizadeh R, et al. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments. Cancer Metastasis Rev. 2024;43:729–53.
Puthia M, et al. Prevention and treatment of colon cancer by peroral administration of HAMLET (human alpha-lactalbumin made lethal to tumour cells). Gut. 2014;63:131–42.
Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422–6.
Zhang L, Shay JW. Multiple roles of APC and its therapeutic implications in colorectal cancer. J Natl Cancer Inst. 2017;109:djw332.
Xue W, et al. Wnt/beta-catenin-driven EMT regulation in human cancers. Cell Mol Life Sci. 2024;81:79.
Nadeem A, et al. Suppression of beta-catenin signaling in colon carcinoma cells by a bacterial protein. Int J Cancer. 2021;149:442–59.
Zhang Y, Wang X. Targeting the Wnt/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13:165.
Wang S, et al. Cell death pathways: molecular mechanisms and therapeutic targets for cancer. MedComm. 2024;5:e693.
Dixon SJ, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72.
Yang WS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317–31.
Ingold I, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172:409–22 e21.
Fu J, et al. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors. Biomaterials. 2021;268:120537.
Hakansson A, et al. Apoptosis induced by a human milk protein. Proc Natl Acad Sci USA. 1995;92:8064–8.
Ho JC, et al. Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism. Oncogene. 2016;35:897–907.
Nadeem A, et al. Beta-sheet-specific interactions with heat shock proteins define a mechanism of delayed tumor cell death in response to HAMLET. J Mol Biol. 2019;431:2612–27.
Nadeem A, et al. Protein receptor-independent plasma membrane remodeling by HAMLET: a tumoricidal protein-lipid complex. Sci Rep. 2015;5:16432.
Svensson M, et al. Conversion of alpha-lactalbumin to a protein inducing apoptosis. Proc Natl Acad Sci USA. 2000;97:4221–6.
Storm P, et al. A unifying mechanism for cancer cell death through ion channel activation by HAMLET. PLoS One. 2013;8:e58578.
Ho JCS, Nadeem A, Svanborg C. HAMLET – a protein-lipid complex with broad tumoricidal activity. Biochem Biophys Res Commun. 2017;482:454–8.
Wilhelm K, et al. Protein oligomerization induced by oleic acid at the solid-liquid interface-equine lysozyme cytotoxic complexes. FEBS J. 2009;276:3975–89.
Brisuda A, et al. Bladder cancer therapy using a conformationally fluid tumoricidal peptide complex. Nat Commun. 2021;12:3427.
Lindback T, et al. Cytotoxicity of the Bacillus cereus Nhe enterotoxin requires specific binding order of its three exoprotein components. Infect Immun. 2010;78:3813–21.
Lindback T, et al. Characterization of the Bacillus cereus Nhe enterotoxin. Microbiology. 2004;150:3959–67.
Ho CS, et al. Low resolution solution structure of HAMLET and the importance of its alpha-domains in tumoricidal activity. PLoS One. 2012;7:e53051.
Chaudhuri A, et al. Protein-dependent membrane interaction of a partially disordered protein complex with oleic acid: implications for cancer lipidomics. Sci Rep. 2016;6:35015.
Sezgin E. Giant plasma membrane vesicles to study plasma membrane structure and dynamics. Biochim Biophys Acta Biomembr. 2022;1864:183857.
Skinkle AD, Levental KR, Levental I. Cell-derived plasma membrane vesicles are permeable to hydrophilic macromolecules. Biophys J. 2020;118:1292–1300.
Zhao L, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun. 2022;42:88–116
Degterev A, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008;4:313–21.
Din MAU, et al. Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets in cancer. Front Pharm. 2024;15:1383203.
Dong K, et al. HOIP modulates the stability of GPx4 by linear ubiquitination. Proc Natl Acad Sci USA. 2022;119:e2214227119.
Gerstle Z, Desai R, Veatch SL. Giant plasma membrane vesicles: an experimental tool for probing the effects of drugs and other conditions on membrane domain stability. Methods Enzymol. 2018;603:129–50.
Duringer C, et al. HAMLET interacts with histones and chromatin in tumor cell nuclei. J Biol Chem. 2003;278:42131–5.
Yan B, et al. Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell. 2021;81:355–69.e10.
Stockwell BR, Jiang X. The chemistry and biology of ferroptosis. Cell Chem Biol. 2020;27:365–75.
Hangauer MJ, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247–50.
Fares J, et al. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5:28.
Tran HT, et al. BAMLET administration via drinking water inhibits intestinal tumor development and promotes long-term health. Sci Rep. 2024;14:3838.
Kepp O, et al. Cell death assays for drug discovery. Nat Rev Drug Discov. 2011;10:221–37.
Nadeem A, et al. Protein-lipid interaction at low pH induces oligomerization of the MakA cytotoxin from Vibrio cholerae. Elife. 2022;11:e73439.
Dutta S, et al. Calcein release assay to measure membrane permeabilization by recombinant alpha-synuclein. Bio Protoc. 2020;10:e3690.
Pijuan J, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front Cell Dev Biol. 2019;7:107.
Cho M, et al. OncoDB 2.0: a comprehensive platform for integrated pan-cancer omics analysis. Nucleic Acids Res. 2025;54:D1537–D1544.
Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–4.

